NCT03707717View on ClinicalTrials.gov

A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

189

Participants

Timeline

Start Date

October 15, 2018

Primary Completion Date

June 5, 2019

Study Completion Date

June 5, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Bimekizumab

Subjects will receive a pre-specified sequence of bimekzumab in the Treatment Period.

Trial Locations (2)

21225

Up0033 002, Baltimore

Unknown

Up0033 001, Berlin

All Listed Sponsors

lead

UCB Biopharma S.P.R.L.

INDUSTRY

NCT03707717 - A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants | Biotech Hunter | Biotech Hunter